Life Sciences Analytics Solutions

Clarify Health's Life Sciences Analytics Solutions is a platform designed for pharmaceutical and biotech companies seeking data-driven insights to support drug development, commercialization, and clinical research. The platform draws on what Clarify describes as one of the most robust real-world data sets in healthcare, enabling life sciences organizations to understand macro-level health outcomes, identify clinical needs, and accelerate research workflows.

The platform is positioned for use across pharmaceutical and biotech teams involved in launch strategy, HCP targeting, patient identification, real-world evidence (RWE) generation, and health equity analysis. Clarify has published collaborative studies with organizations including Pfizer, Merck, Bristol-Myers Squibb, Novo Nordisk, and Boehringer Ingelheim.

Core Capabilities

• Patient identification for newly launched or pipeline drugs using real-world claims data
• HCP targeting and decile assignment to prioritize outreach for commercial teams
• Real-world data (RWD) studies and custom research addressing specific business questions across all aspects of healthcare
• Deep-dive insights through expert advisory services for complex care and commercial decisions
• Analysis of social determinants of health (SDoH) and behavioral social determinants of health (SBDoH) to support health equity initiatives
• Patient journey analytics, including self-service tools for illuminating care pathways
• Medication adherence studies across populations, including Medicaid, commercial, and rare disease patient groups
• Diagnostic testing pattern analysis for rare disease and specialty populations

Commercial and Launch Support

• Supports pharmaceutical commercialization strategy, including market access reporting and BD&L (business development and licensing) analytics
• Enables identification of target HCPs, with reported outcomes including 33% more target HCPs identified in documented use cases
• Assists in estimating revenue potential and prioritizing field force outreach lists
• Addresses gaps in traditional pharmaceutical commercialization models through data-informed approaches
• Provides insights relevant to therapy launch across rare disease, oncology, and other specialty areas

Clinical Research and Real-World Evidence

• Supports clinical trial design and recruitment using real-world evidence
• Helps identify clinical trial sites using SDoH data
• Addresses diversity, equity, and inclusion (DE&I) requirements in clinical trials, including alignment with FDA recommendations for Race and Ethnicity Diversity Plans submitted by trial sponsors
• Supports generation and publication of peer-reviewed RWE studies in collaboration with pharmaceutical partners
• Covers novel use cases for precision analytics across diagnostics, medical devices, and digital therapeutics

Reported Outcomes

• Identification of more than 13,000 patients suitable for a newly launched drug for a global biopharma manufacturer
• Pinpointing of more than 100 physicians for potential outreach in a single engagement
• Estimated revenue potential increased to $300 million for a biopharma client
• $35 million in revenue growth reported in year one for a documented client case

Clarify Health offers personalized demos and positions its solutions as modular building blocks that can be combined to support different stages of pharmaceutical development and commercialization. The platform incorporates SDoH data and health equity analytics as components of both commercial strategy and clinical research design.